AHA Healthier Together Conference concludes with sessions on AI, person-centered care

May 14, 2026 - 02:06 PM
2026 Healthier Together Conference Day 3

The AHA wrapped up its inaugural Healthier Together Conference in Dallas May 14 with a plenary session on how the application of artificial intelligence-driven tools and data insights is advancing community health. Speakers Jennifer Hall, Ph.D., chief of data science and analytics at the American Heart Association, and Roberta Levy Schwartz, Ph.D., executive vice president and chief innovation officer at Houston Methodist Hospital, discussed promising AI innovations and potential pitfalls with Chris DeRienzo, M.D., AHA chief physician executive.

Other closing day highlights included breakout sessions on collaborations to improve rural, behavioral and youth health; innovative approaches to social needs screening; and ways to strengthen person-centered care by integrating caregivers into Age Friendly Health Systems.

Related News Articles

Headline
AHA comments on cybersecurity, AI attacks for Senate Homeland Security subcommittee hearing
The AHA provided comments Sept. 30 to the Senate Homeland Security and Governmental Affairs Subcommittee on Disaster Management, District of Columbia and…
Headline
White House announces AI-powered website for delivering government information, services
Two executive orders on artificial intelligence were released Sept. 29 by the White House. One announced a new website that will use AI to deliver federal…
Headline
AHA podcast: Top 3 Healthcare Cyber Threats in 2026 
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…
Headline
Fact sheet details why use of AI alleviates burden for providers and does not improperly increase coding intensity 
The AHA has released a fact sheet explaining how artificial intelligence tools help alleviate administrative burden for providers, particularly in areas such…
Headline
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices
The Food and Drug Administration is seeking public feedback on a discussion paper released today on potential regulatory approaches for generative artificial…
Headline
AHA responds to FDA RFI on health and safety benefits regarding non-device software
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…